-
Breast Cancer Drug Costs Vary Among Insured Patients
Women receiving chemotherapy for breast cancer can face widely different costs for their treatments, regardless of effectiveness, even if they have health insurance.
-
Funds Provided for Developing RNA-Based Zika Vaccine
Researchers from Infectious Disease Research Institute, or Idri, are receiving funding from National Institutes of Health to develop a new type of vaccine for the Zika virus.
-
Grant Funding Study of Gut Microbe Protection Drug
A biotechnology company developing drugs that protect the natural microbial balance in the gastrointestinal tract is receiving funds to learn how its drugs affect antibiotic resistance.
-
Adverse Effects Reports in Cancer Trials Seen Lacking
A review of clinical trials testing targeted treatments or immunotherapies for cancer show most of the studies got low scores on a standard scale for reporting adverse side effects.
-
Fuel Cell Vehicles Reach Market, Seek Critical Mass
As the first hydrogen fuel cell vehicles go on sale, a group of companies and government agencies are seeking ways to encourage sales to help meet national goals for reducing greenhouse gases.
-
Vaccine Stops Livestock Infections Without Antibiotics
A veterinary medical team at Kansas State University developed a vaccine that protects livestock against dangerous liver and skin infections without antibiotics.
-
Deep Sequencing Reveals 150M Rare, Unknown Variations
A company formed to solve age-related medical problems performed an in-depth sequencing of more than 10,000 human genomes, revealing 150 million new or uncommon genetic variations.
-
Precision Medicine Trial Set for Pancreatic Cancer
A large-scale clinical trial is planned at 12 sites in the U.S. to test treatments for pancreatic cancer guided by the genomics of a patient’s own tumor.
-
Shanah Tovah 5777
Science and Enterprise is taking off on Monday, 3 October to observe Rosh Hashanah, the Jewish new year.
-
Challenge Seeks Gastrointestinal Toxicity Test Methods
A challenge competition on InnoCentive sponsored by AstraZeneca is looking for new lab tests for toxic effects of drugs on the gastrointestinal tract.